SF17 Therapeutics' Seed Round

SF17 Therapeutics raised a round of funding on July 25, 2018. Investors include Y Combinator.

SF17 Therapeutics is a precision medicine analytics platform providing monitoring for pediatric rheumatologists for life-threatening conditions.…

Articles about SF17 Therapeutics' Seed Round: